Bacterin International Revenue Quarterly YoY Growth:
-10.76% for Dec. 31, 2012Bacterin International Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -10.76% |
| Sept. 30, 2012 | 17.78% |
| June 30, 2012 | 9.32% |
| March 31, 2012 | 29.48% |
| Dec. 31, 2011 | 72.10% |
| Sept. 30, 2011 | 79.86% |
| June 30, 2011 | 134.6% |
| March 31, 2011 | 119.3% |
| Dec. 31, 2010 | 141.4% |
| Sept. 30, 2010 | 203.1% |
| June 30, 2010 | 85.95% |
| March 31, 2010 | 10954% |
| Dec. 31, 2009 | 2996% |
| Sept. 30, 2009 | 415.3% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
BONE Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Abiomed | 16.95% |
| Guided Therapeutics | 9.88% |
| Smith & Nephew | -0.37% |
BONE Revenue Quarterly YoY Growth Rankings
| Overall |
49th percentile 4059 of 8002 |
| Sector |
38th percentile 403 of 650 in Healthcare |
| Industry |
17th percentile 74 of 90 in Medical Devices |
BONE Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -10.76% | Dec 2012 |
| Maximum | 10954% | Mar 2010 |
| Average | 1089% |
